• Consensus Rating: Hold
  • Consensus Price Target: $3.00
  • Forecasted Upside: 1,121.50%
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.25
▼ -0.0027 (-1.09%)

This chart shows the closing price for HLTH by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Cue Health Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for HLTH and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for HLTH

Analyst Price Target is $3.00
▲ +1,121.50% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Cue Health in the last 3 months. The average price target is $3.00, with a high forecast of $3.00 and a low forecast of $3.00. The average price target represents a 1,121.50% upside from the last price of $0.25.

This chart shows the closing price for HLTH for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 1 polled investment analysts is to hold stock in Cue Health. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/5/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/4/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/4/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/2/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
8/31/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
11/29/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
1/28/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
2/27/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/2/2023The Goldman Sachs GroupDowngradeBuy ➝ NeutralLow
5/15/2023BTIG ResearchLower Target$5.00 ➝ $3.00Low
11/15/2022BTIG ResearchLower Target$7.00Low
11/14/2022CowenLower TargetOutperform$9.00 ➝ $7.00Low
11/14/2022CowenLower TargetOutperform$9.00 ➝ $7.00Low
10/21/2022The Goldman Sachs GroupLower TargetBuy$7.00 ➝ $6.00Low
8/15/2022CowenLower Target$9.00N/A
8/15/2022BTIG ResearchLower Target$9.00N/A
8/11/2022Morgan StanleyLower TargetEqual Weight$10.00 ➝ $8.00Low
(Data available from 2/28/2019 forward)

News Sentiment Rating

0.42 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/2/2023
  • 2 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/1/2023
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/1/2023
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/31/2023
  • 1 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/30/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/30/2023
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/29/2024
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/28/2024

Current Sentiment

  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.
Cue Health logo
Cue Health Inc., a healthcare technology company, designs and develops diagnostic platform for diagnostic tests for individuals, enterprises, healthcare providers and payors, and public health agencies. It offers Cue Integrated Care platform comprising hardware and software components, such as Cue Health Monitoring System consisting of Cue Reader, a portable and reusable reader, Cue Cartridge, a single-use test cartridge, and Cue Wand, a sample collection wand; Cue Data and Innovation Layer, a solution with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, which include Cue Health App and Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, a solution that allows integrations with third-party applications and sensors. The company also provides COVID-19 testing kits for the Cue Health Monitoring System The company was formerly known as Cue Inc and changed its name to Cue Health Inc. in December 2017. Cue Health Inc. was incorporated in 2010 and is headquartered in San Diego, California.
Read More

Today's Range

Now: $0.25
Low: $0.25
High: $0.26

50 Day Range

MA: $0.23
Low: $0.16
High: $0.30

52 Week Range

Now: $0.25
Low: $0.16
High: $2.37

Volume

51,751 shs

Average Volume

1,130,601 shs

Market Capitalization

$37.98 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.07

Frequently Asked Questions

What sell-side analysts currently cover shares of Cue Health?

The following equities research analysts have issued research reports on Cue Health in the last year: BTIG Research, and The Goldman Sachs Group, Inc..
View the latest analyst ratings for HLTH.

What is the current price target for Cue Health?

1 Wall Street analysts have set twelve-month price targets for Cue Health in the last year. Their average twelve-month price target is $3.00, suggesting a possible upside of 1,108.2%. BTIG Research has the highest price target set, predicting HLTH will reach $3.00 in the next twelve months. BTIG Research has the lowest price target set, forecasting a price of $3.00 for Cue Health in the next year.
View the latest price targets for HLTH.

What is the current consensus analyst rating for Cue Health?

Cue Health currently has 1 hold rating from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in HLTH, but not buy more shares or sell existing shares.
View the latest ratings for HLTH.

What other companies compete with Cue Health?

How do I contact Cue Health's investor relations team?

Cue Health's physical mailing address is 4980 CARROLL CANYON ROAD SUITE 100, SAN DIEGO CA, 92121. The company's listed phone number is 858-412-8151 and its investor relations email address is [email protected]. The official website for Cue Health is www.cuehealth.com. Learn More about contacing Cue Health investor relations.